Avantium NV
AEX:AVTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (8.5), the stock would be worth €5.21 (29% downside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 11.9 | €7.3 |
0%
|
| 3-Year Average | 8.5 | €5.21 |
-29%
|
| 5-Year Average | 8 | €4.89 |
-33%
|
| Industry Average | 4.1 | €2.5 |
-66%
|
| Country Average | 1.8 | €1.11 |
-85%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
€173.7m
|
/ |
Jan 2026
€14.6m
|
= |
|
|
€173.7m
|
/ |
Dec 2026
€49.1m
|
= |
|
|
€173.7m
|
/ |
Dec 2027
€78.4m
|
= |
|
|
€173.7m
|
/ |
Dec 2028
€88m
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| NL |
|
Avantium NV
AEX:AVTX
|
184m EUR | 11.9 | -8.2 | |
| UK |
|
Relx PLC
LSE:REL
|
49B GBP | 5.7 | 23.7 | |
| UK |
I
|
IHS Markit Ltd
F:0M3
|
37.9B EUR | 10.2 | 36.5 | |
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
55B CAD | 5.4 | 26.1 | |
| IE |
|
Experian PLC
LSE:EXPN
|
25.1B GBP | 4.7 | 24.6 | |
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
24.6B USD | 8.3 | 27.1 | |
| CH |
|
SGS SA
SIX:SGSN
|
16.5B CHF | 2.6 | 24.6 | |
| US |
|
Equifax Inc
NYSE:EFX
|
20.6B USD | 3.9 | 29.4 | |
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
18.5B USD | 1.3 | 12.7 | |
| US |
U
|
UL Solutions Inc
NYSE:ULS
|
18.1B USD | 0 | 0 | |
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
15B EUR | 3 | 11.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.1 |
| Median | 1.8 |
| 70th Percentile | 4.2 |
| Max | 483 448.2 |
Other Multiples
Avantium NV
Glance View
Avantium NV engages in the development and commercialization of bio-based plastics and chemicals using advanced catalysis research and development. The company is headquartered in Amsterdam, Noord-Holland and currently employs 213 full-time employees. The company went IPO on 2017-03-15. The firm develops chemical technologies and production processes to convert bio-based feedstock into sustainable products. The firm's business comprises three segments: Catalysis, Renewable Chemistries, and YXY. Catalysis segment provides catalysis R&D services and systems to chemical, refinery and energy companies, utilizing its Flowrence Technology Platform to devise the appropriate catalyst testing solutions. Renewable Chemistries is the development division with a portfolio of projects focusing on the conversion of biomass to chemical building blocks and plastic materials. The YXY segment comprises the activities of Syviana, the joint venture with BASF SE. The YXY technology is used to convert plant-based sugars into chemical building blocks for plastics, such as polymer polyethylenefuranoate (PEF), and other applications.
